Selitrectinib
- Generic Name
- Selitrectinib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C20H21FN6O
- CAS Number
- 2097002-61-2
- Unique Ingredient Identifier
- 0J45910S3X
- Background
Selitrectinib is under investigation in clinical trial NCT03215511 (Phase 1/2 Study of LOXO-195 in Patients With Previously Treated NTRK Fusion Cancers).
- Associated Conditions
- -
- Associated Therapies
- -
No trials found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath